Skip to main content
Premium Trial:

Request an Annual Quote

Foundation Medicine Added to Nasdaq Biotech Index

NEW YORK (GenomeWeb) — Foundation Medicine said today that the company has been added to the Nasdaq Biotechnology Index. 

The index tracks Nasdaq-listed securities that are classified as either biotechnology or pharmaceutical by the Industry Classification Benchmark. The index, which is reranked each year, is also the basis for the iShares Nasdaq Biotechnology Index Fund. The fund seeks investment results corresponding generally to the price and yield performance of the Nasdaq Biotechnology Index, and options based on the index fund trade on various exchanges. 

A total of 44 firms were added to the index, while eight were removed, including Cellular Dynamics International. 

In morning trading on Tuesday, shares of Foundation Medicine were up a fraction of 1 percent at $21.01. 

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.